Grow Your Wealth
with Mutual Funds
Motilal Oswal Bse Healthcare Etf-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 41.9 Cr.
NAV as on 03 aug, 2026
₹ 51.51
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Motilal Oswal Bse Healthcare Etf-growth
Inception Date
29 Jul 2022
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
99.82%
Cash
0.18%
Portfolio Updated on: 10 Jul, 2026
Sector Allocations
Equity
Healthcare
Portfolio Updated on: 03 aug, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 14.43% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.90% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.90% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.46% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.87% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.87% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 14.08% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.16% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.40% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.20% |
Debt & Credit Risk Analysis
| Alpha | -0.23% |
| Beta | 1.00% |
| R2 | 1.00% |
| Sharpe Ratio | 0.99% |
| Standard Deviation | 16.29% |
| Sortino Ratio | 1.52% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 14.04% | NA | 6.12% |
| 6 Months | 20.52% | NA | 12.92% |
| 9 Months | 13.05% | NA | 4.47% |
| 1 Year | 14.93% | 14.93% | 6.04% |
| 2 Years | 25.08% | 11.84% | 24.93% |
| 3 Years | 84.86% | 22.73% | 25.71% |
Motilal Oswal Bse Healthcare Etf-growth is one Equity mutual fund offered by Motilal Oswal Mutual Fund. Launched on 29 Jul 2022, the fund aims Return that corresponds to the performance of S&P BSE Healthcare Total Return Index subject to tracking error. Long term capital growth. It manages assets worth ₹41.9 crore as on Tue Jun 30, 2026. The expense ratio stands at 0.43%.
Dishant Mehta has experience Mr. Dishant Mehta has more than 11 years of experience and expertise in Financial markets across different segment -Equities, Derivatives, Commodities and Currencies
Rakesh Shetty has experience Prior to joining Motilal Oswal Mutual Fund, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
Swapnil P Mayekar has experience Prior to joining Motilal Oswal AMC he worked with Business Standard Limited from Aug 2005 to Feb 2010.
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund-growth | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| SBI Healthcare Opportunities Fund-idcw | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| DSP Healthcare Fund Direct-growth | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| DSP Healthcare Fund Direct-idcw | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| Mirae Asset Healthcare Fund Direct-growth | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
| Mirae Asset Healthcare Fund Direct-idcw | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Motilal Oswal Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth | 40.0 | +1.77% | +14.98% | +22.76% | +15.52% | — | — |
| Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth | 40.0 | +1.80% | +15.11% | +23.03% | +16.04% | — | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹595.67 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹413.85 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹514.75 | +23.32% | +16.75% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹324.27 | +23.32% | +16.75% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.77 | +24.03% | +16.63% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.85 | +24.03% | +16.63% | — |
| Dsp Healthcare Fund Direct-growth | ₹49.33 | +21.00% | +15.99% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.53 | +21.00% | +15.99% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹51.65 | +23.87% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹31.11 | +23.87% | +15.83% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 03 Aug 2026 | ₹51.51 |
| 31 Jul 2026 | ₹51.55 |
| 30 Jul 2026 | ₹51.45 |
| 29 Jul 2026 | ₹51.56 |
| 28 Jul 2026 | ₹50.92 |
| 27 Jul 2026 | ₹50.93 |
| 24 Jul 2026 | ₹50.13 |
| 23 Jul 2026 | ₹50.27 |
| 22 Jul 2026 | ₹50.53 |
| 21 Jul 2026 | ₹51.19 |
| 20 Jul 2026 | ₹51.06 |
| 17 Jul 2026 | ₹50.50 |
| 16 Jul 2026 | ₹51.09 |
| 15 Jul 2026 | ₹51.13 |
| 14 Jul 2026 | ₹50.87 |
| 13 Jul 2026 | ₹50.60 |
| 10 Jul 2026 | ₹50.60 |
| 09 Jul 2026 | ₹50.45 |
| 08 Jul 2026 | ₹49.85 |
| 07 Jul 2026 | ₹50.41 |
| 06 Jul 2026 | ₹50.75 |
| 03 Jul 2026 | ₹50.72 |
| 02 Jul 2026 | ₹50.06 |
| 01 Jul 2026 | ₹49.74 |
| 30 Jun 2026 | ₹49.93 |
| 29 Jun 2026 | ₹49.64 |
| 25 Jun 2026 | ₹49.18 |
| 24 Jun 2026 | ₹49.21 |
| 23 Jun 2026 | ₹49.14 |
| 22 Jun 2026 | ₹48.84 |
Portfolio Updated on: 04 Aug, 2026
Fund Growth & Size Analysis
+₹41.9 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Motilal Oswal Bse Healthcare Etf-growth Returns Comparison
Compare Motilal Oswal Bse Healthcare Etf-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Motilal Oswal Bse Heal....
No funds found for your search.
Motilal Oswal Bse Healthcare Etf-growth FAQ'S
- Sharpe Ratio: 0.99%
- Standard Deviation: 16.29%
- Beta: 1.00%
- Alpha: -0.23%
- R-squared: 1.00%
- Information Ratio: -4.46%
- Sortino Ratio: 1.52%
Additional important ratios:
As of Tue Jun 30, 2026, the total assets managed under Motilal Oswal Bse Healthcare Etf-growth stand at approximately ₹ 41.9 crore.
The Motilal Oswal Bse Healthcare Etf-growth has delivered the following short-term performance:
- 3 Months Return: 14.04%
- 6 Months Return: 20.52%
The historical growth of the Motilal Oswal Bse Healthcare Etf-growth is reflected through its CAGR returns:
- 3 Year CAGR: 22.73%
- Return Since Launch: 21.99%
The portfolio of Motilal Oswal Bse Healthcare Etf-growth is distributed across different asset classes as follows:
- Equity: 99.82%
- Other Assets: 0.18%
The Motilal Oswal Bse Healthcare Etf-growth is managed by Swapnil P Mayekar, representing Motilal Oswal Mutual Fund.
The Motilal Oswal Bse Healthcare Etf-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 32.27%
- Mid Cap Stocks: 40.72%
- Small Cap Stocks: 27.01%
Top stock holdings of Motilal Oswal Bse Healthcare Etf-growth include:
- Sun Pharmaceutical Industries Ltd – represents 14.43% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.90% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.90% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.46% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.87% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.87% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 14.08% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.16% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.40% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.20% of the portfolio
Major sector exposures in Motilal Oswal Bse Healthcare Etf-growth are:
- Healthcare – accounts for 1,203.82% of the portfolio
